Inspire Medical Systems (INSP) to Release Quarterly Earnings on Tuesday

Inspire Medical Systems (NYSE:INSP) is scheduled to be announcing its earnings results after the market closes on Tuesday, May 7th. Analysts expect the company to announce earnings of ($0.63) per share for the quarter. Investors that are interested in registering for the company’s conference call can do so using this link.

Inspire Medical Systems (NYSE:INSP) last announced its quarterly earnings results on Tuesday, February 6th. The company reported $0.49 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.53. Inspire Medical Systems had a negative return on equity of 3.93% and a negative net margin of 3.39%. The business had revenue of $192.51 million during the quarter, compared to analysts’ expectations of $186.75 million. During the same quarter last year, the business posted $0.10 earnings per share. The business’s revenue for the quarter was up 39.6% on a year-over-year basis. On average, analysts expect Inspire Medical Systems to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Inspire Medical Systems Stock Up 2.7 %

Shares of INSP stock opened at $243.84 on Tuesday. Inspire Medical Systems has a fifty-two week low of $123.27 and a fifty-two week high of $330.00. The stock has a market cap of $7.39 billion, a P/E ratio of -329.51 and a beta of 1.37. The business has a fifty day simple moving average of $208.56 and a 200-day simple moving average of $186.65.

Wall Street Analyst Weigh In

A number of research firms recently commented on INSP. Morgan Stanley began coverage on Inspire Medical Systems in a research report on Tuesday, March 19th. They set an “overweight” rating and a $250.00 price objective for the company. Stifel Nicolaus reiterated a “hold” rating and set a $210.00 price objective on shares of Inspire Medical Systems in a research report on Tuesday, January 2nd. Truist Financial reiterated a “buy” rating and set a $280.00 price objective on shares of Inspire Medical Systems in a research report on Wednesday, March 20th. Jefferies Financial Group assumed coverage on Inspire Medical Systems in a research note on Friday, January 19th. They issued a “buy” rating and a $245.00 price target on the stock. Finally, Royal Bank of Canada assumed coverage on Inspire Medical Systems in a research note on Friday, April 19th. They issued an “outperform” rating and a $285.00 price target on the stock. Four analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $272.20.

Insider Activity

In related news, insider Randy Ban sold 12,230 shares of the business’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $185.37, for a total transaction of $2,267,075.10. Following the transaction, the insider now directly owns 3,029 shares of the company’s stock, valued at approximately $561,485.73. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, insider Randy Ban sold 12,230 shares of the business’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $185.37, for a total transaction of $2,267,075.10. Following the transaction, the insider now directly owns 3,029 shares of the company’s stock, valued at approximately $561,485.73. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Jerry C. Griffin sold 554 shares of the business’s stock in a transaction that occurred on Monday, March 18th. The stock was sold at an average price of $193.53, for a total value of $107,215.62. Following the transaction, the director now directly owns 10,190 shares in the company, valued at $1,972,070.70. The disclosure for this sale can be found here. Insiders have sold 76,371 shares of company stock valued at $15,664,278 in the last three months. Corporate insiders own 4.10% of the company’s stock.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.